Inovio Pharmaceuticals (INO) Stock Price

$2.24 0.9%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    2

  • Fundamental

    1

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Inovio Pharmaceuticals, AI stock picks, stock alerts and much more.

Sign up

INO AI Stock Analysis

AI stock analysis for INO is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Inovio Pharmaceuticals (INO) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Inovio Pharmaceuticals (INO) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Inovio Pharmaceuticals (INO), currently trading at $2.24, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About INO

LSE

  • Inovio Pharmaceuticals, Inc.

  • Symbol

    INO

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    80.9M

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6
CRSP Crispr Therapeutics
CRSP		 $47.91
5%
6

News

Here's Why Inovio (INO) Could be Great Choice for a Bottom Fisher

Here's Why Inovio (INO) Could be Great Choice for a Bottom Fisher
February 12, 2025. zacks.com
Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
February 10, 2025. prnewswire.com
INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
January 9, 2025. prnewswire.com
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet

Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet
December 13, 2024. benzinga.com

INO Alternative Data

Web Traffic

Inovio Pharmaceuticals receives an estimated 9962 monthly visitors to inovio.com.

  • Web Traffic

    9962

  • Change from Previous Month

    47.9%

  • 3 Month Change

    11.4%

  • YoY Change

    11.4%

News Mentions

Inovio Pharmaceuticals was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

Reddit Mentions

Inovio Pharmaceuticals has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    1

  • Daily Change

    0%

Twitter Followers

Inovio Pharmaceuticals has 17,217 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.4% over the last month.

  • Twitter Followers

    17217

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    0.9%

  • YoY Change

    0.9%

Facebook Engagement

Inovio Pharmaceuticals has engaged 14 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    14

  • Daily Change

    30%

  • 1 Month Change

    0%

  • 3 Month Change

    30%

  • YoY Change

    30%

Youtube Subscribers

Inovio Pharmaceuticals has 1,050 subscribers on its main Youtube channel.

  • Youtube Subscribers

    1050

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    1%

  • YoY Change

    1%

LinkedIn Followers

25,708 are following Inovio Pharmaceuticals on LinkedIn, up by 0.5% over the last month.

  • LinkedIn Followers

    25708

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    1%

Job Postings

Inovio Pharmaceuticals currenly has an estimated 3 open job postings.

  • Job Postings

    3

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Inovio Pharmaceuticals has 215 employees, down by -0.9% over the last month.

  • LinkedIn Employees

    215

  • Daily Change

    0%

  • 1 Month Change

    0.9%

  • 3 Month Change

    1.8%

  • YoY Change

    1.8%

Business Outlook

  • Business Outlook

    19

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

INO Financials

INO Key Metrics

  • Total Revenue

    $0

  • Net Income

    -$25.2B

  • Earnings per Share

    -$894.28

  • Free cash flow

    -$84.4B

  • EBITDA

    -$24.4M

  • EBITDA Ratio

    0

  • Total Assets

    $107.1M

INO 2-year Revenue & Income
INO 2-year Free Cash Flow

INO Technicals

INO SMA
INO RSI

FAQ

What's the current price of Inovio Pharmaceuticals (INO) Stock?
The price of an Inovio Pharmaceuticals (INO) share is $2.24.

What's the market cap of Inovio Pharmaceuticals?
The current market cap of Inovio Pharmaceuticals is 80.9M.

Should I buy or sell INO?
Inovio Pharmaceuticals exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Inovio Pharmaceuticals a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Inovio Pharmaceuticals stock. There are several bearish signals and market challenges that could negatively impact Inovio Pharmaceuticals' future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Inovio Pharmaceuticals (INO) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Inovio Pharmaceuticals stock right now, as the outlook appears bearish.

What are some stocks similar to Inovio Pharmaceuticals (INO) that investors often compare it to?
Inovio Pharmaceuticals (INO) is often compared to similar stocks such as Catalyst Pharmaceuticals, Moderna, Anavex Life Sciences, BridgeBio Pharma and Crispr Therapeutics.

What is the forecast for Inovio Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Inovio Pharmaceuticals' stock price to be around $1.96 in 2026. Starting from the current price of $2.24, this represents a 12.7% change in price, indicating a bearish outlook for the stock.

How to buy Inovio Pharmaceuticals (INO) Stock?
Inovio Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Inovio Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.